Protecting-group-lean platform for synthesizing diverse phenylethanoid glycosides uncovers antifibrotic leads
Phenylethanoid glycosides are structurally diverse natural products widely found in traditional medicinal plants and display a broad range of biological activities. However, systematic studies of their functions and structure–activity relationships have been limited by inefficient access to diverse analogs in useful quantities. Here we show a protecting-group-lean synthetic platform that provides a 29-member library of phenylethanoid glycosides with variations at four positions of the central glucose unit. The strategy combines regioselective glycosylation, β-selective glycosylation without neighboring-group assistance, selective caffeoylation, and a mild global deprotection that preserves labile caffeoyl esters. Two glycosylations and two additional transformations can be performed sequentially in one pot, substantially streamlining assembly. Biological evaluation in a TGF-β-induced fibroblast model reveals structure–activity relationships, provides insight into signaling pathways associated with antifibrotic activity, and identifies several compounds as promising leads for further antifibrotic studies.
Authors
- Shiyang Shen (ORCID: https://orcid.org/0009-0007-8895-7788)
- Yugen Zhu (ORCID: https://orcid.org/0000-0002-7864-7045)
- Kai Chen (ORCID: https://orcid.org/0000-0003-1012-0383)
- Banhao Kuang
- Xinyang Jiang
- Yu-Cheng Peng
- Weiwen Wang
- Gang Yang
- Qian Zhang
- Ruibo Lin
Institutions
- Central South University (CN)
- Guiyang Medical University (CN)
- Chinese Academy of Sciences (CN)
- Shanghai Institute of Materia Medica (CN)
- University of Chinese Academy of Sciences (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Nature Communications
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1038/s41467-026-79652-w
- Primary Topic
- Carbohydrate Chemistry and Synthesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00